Gartner Blog Network

2 x Life Science Hype Cycles

by Michael Shanler  |  July 29, 2017  |  Comments Off on 2 x Life Science Hype Cycles

While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing,  re-reviewing, re-re-reviewing our content.  After countless cups of coffee, our 2 x hype cycles that cover the life science industry are finally published.  These docs are relevant for CIOs, IT and business leaders that run organizations at pharma, biotech, med-device, and CROs.  Roles representing other highly-regulated science-based product development industries (e.g. cosmetics, nutriceuticals, food & beverage) may also find these hype cycles interesting.

Keep in mind the relationship between these two documents-

~80 technologies are covered in these 2 x hype cycles.   Since “life science” is a bit of a moving target and we see disruption happening on the fringe with health care industry segments, it might pay to become familiar with these other HC docs, as  well:

Of course, there are specialty non-industry specific hype cycles, too.    For example:


Additional Resources

View Free, Relevant Gartner Research

Gartner's research helps you cut through the complexity and deliver the knowledge you need to make the right decisions quickly, and with confidence.

Read Free Gartner Research

Category: cio  clinical-development  cloud  compliance  ctms  data-and-analytics-strategies  digital  digital-marketing  eclinical  edc  engineering  epro  gartner  hype-cycle  innovation  internet-of-everything  internet-of-things  iolt  iot  it  it-cost-optimization  laboratories  laboratory  manufacturing  mobile-and-endpoint-technologies  nof  pharma  pharmaceutical  product-development  rd  regulatory  science  security  supply-chain  technology-and-emerging-trends  transformation  wearables  

Tags: big-data  bigdata  cio  cloud  collaboration  digital  eln  informatics  innovation  iot  rd  science-2  

Michael Shanler
Research VP
5 years at Gartner

Michael Shanler covers life science R&D technologies. Read Full Bio

Comments are closed

Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.